Suppr超能文献

体位性心动过速综合征患者惊恐样症状的实验性诱发

Experimental induction of panic-like symptoms in patients with postural tachycardia syndrome.

作者信息

Khurana Ramesh K

机构信息

Division of Neurology, The Union Memorial Hospital, Baltimore, MD 21218, USA.

出版信息

Clin Auton Res. 2006 Dec;16(6):371-7. doi: 10.1007/s10286-006-0365-0. Epub 2006 Aug 16.

Abstract

Patients with postural tachycardia syndrome (POTS) might be misdiagnosed with panic disorder due to shared clinical features. The first aim of our study was to investigate the relationship between symptoms of POTS and panic disorder. The second aim was to delineate clinical features distinguishing symptoms of POTS from panic disorder. A total of 11 patients with POTS and 11 control subjects participated in an IRB-approved, prospective, placebo-controlled study. The experimentally induced panic-like symptoms of POTS were systematically studied using the Acute Panic Inventory (API) questionnaire. The participants answered the questionnaire after each placebo infusion and after each of the three provoking stimuli: head-up tilt test (HUT), isoproterenol infusion (ISI), and sodium lactate infusion (SLI). API responses were summed for each subject at each time point of administration. Individual API symptoms and summed responses were analyzed for statistical significance. All patients with POTS developed symptoms of orthostatic intolerance during HUT. Pharmacologically induced symptoms subjectively mimicked spontaneous symptoms in 5 of 11 patients during ISI and in none of 11 patients during SLI. In contrast, API scores in these patients reached panic threshold in 0 of 11 following HUT, in 4 of 11 following ISI and in 4 of 11 following SLI. Individual symptoms analysis revealed that significant increase in scores was limited to the somatic symptoms of palpitations, dyspnea, and twitching or trembling. In conclusion, the symptoms of POTS are phenomenologically different and clinically distinguishable from panic disorder symptoms.

摘要

体位性心动过速综合征(POTS)患者可能因临床特征相似而被误诊为惊恐障碍。我们研究的首要目的是调查POTS症状与惊恐障碍之间的关系。第二个目的是明确区分POTS症状与惊恐障碍症状的临床特征。共有11例POTS患者和11名对照受试者参与了一项经机构审查委员会批准的前瞻性安慰剂对照研究。使用急性惊恐量表(API)问卷对POTS实验诱导的类似惊恐症状进行了系统研究。参与者在每次输注安慰剂后以及在三种激发刺激(头高位倾斜试验(HUT)、异丙肾上腺素输注(ISI)和乳酸钠输注(SLI))中的每一种之后回答问卷。在给药的每个时间点对每个受试者的API反应进行汇总。对个体API症状和汇总反应进行统计学显著性分析。所有POTS患者在HUT期间均出现体位性不耐受症状。在ISI期间,11例患者中有5例药物诱导的症状主观上类似于自发症状,而在SLI期间,11例患者中无一例出现这种情况。相比之下,这些患者的API评分在HUT后11例中有0例达到惊恐阈值,在ISI后11例中有4例达到惊恐阈值,在SLI后11例中有4例达到惊恐阈值。个体症状分析显示,评分显著增加仅限于心悸、呼吸困难以及抽搐或颤抖等躯体症状。总之,POTS的症状在现象学上与惊恐障碍症状不同,在临床上也可区分。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验